Bionano Genomics, Inc. (BNGO) Operating margin 2017–2025
Bionano Genomics, Inc. (BNGO) operating margin by fiscal year — reported operating income divided by reported revenue.
-116.9%FY2025 · since FY2017: -244.3% → -116.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -116.9% | +220.9 pp |
| FY2024 | -337.9% | +258.1 pp |
| FY2023 | -596.0% | -122.3 pp |
| FY2022 | -473.7% | -44.9 pp |
| FY2021 | -428.8% | +24.6 pp |
| FY2020 | -453.4% | -197.9 pp |
| FY2019 | -255.4% | -85.3 pp |
| FY2018 | -170.1% | +74.2 pp |
| FY2017 | -244.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice